HilleVax (HLVX)
(Real Time Quote from BATS)
$12.51 USD
-0.30 (-2.34%)
Updated Apr 24, 2024 03:28 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Balance Sheet
Fiscal Year End for HilleVax, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 303 | 279 | 125 | -99,999 | -99,999 |
Receivables | 0 | 0 | 0 | NA | NA |
Notes Receivable | 0 | 0 | 0 | NA | NA |
Inventories | 0 | 0 | 0 | NA | NA |
Other Current Assets | 7 | 11 | 0 | NA | NA |
Total Current Assets | 311 | 291 | 125 | NA | NA |
Net Property & Equipment | 14 | 6 | 0 | NA | NA |
Investments & Advances | 0 | 0 | 0 | NA | NA |
Other Non-Current Assets | 0 | 0 | 0 | NA | NA |
Deferred Charges | 0 | 0 | 0 | NA | NA |
Intangibles | 0 | 0 | 0 | NA | NA |
Deposits & Other Assets | 2 | 2 | 2 | NA | NA |
Total Assets | 344 | 317 | 127 | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | NA | NA |
Accounts Payable | 7 | 5 | 1 | NA | NA |
Current Portion Long-Term Debt | 0 | 0 | 158 | NA | NA |
Current Portion Capital Leases | 0 | 0 | 0 | NA | NA |
Accrued Expenses | 19 | 8 | 12 | NA | NA |
Income Taxes Payable | 0 | 0 | 0 | NA | NA |
Other Current Liabilities | 0 | 0 | 56 | NA | NA |
Total Current Liabilities | 29 | 13 | 228 | NA | NA |
Mortgages | 0 | 0 | 0 | NA | NA |
Deferred Taxes/Income | 0 | 0 | 0 | NA | NA |
Convertible Debt | 0 | 0 | 0 | NA | NA |
Long-Term Debt | 25 | 15 | 0 | NA | NA |
Non-Current Capital Leases | 0 | 0 | 0 | NA | NA |
Other Non-Current Liabilities | 2 | 1 | 0 | NA | NA |
Minority Interest (Liabilities) | 0 | 0 | 0 | NA | NA |
Total Liabilities | 79 | 50 | 228 | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | NA | NA |
Common Stock (Par) | 0 | 0 | 0 | NA | NA |
Capital Surplus | 655 | 533 | 4 | NA | NA |
Retained Earnings | -389 | -265 | -105 | NA | NA |
Other Equity | -1 | 0 | 0 | NA | NA |
Treasury Stock | 0 | 0 | 0 | NA | NA |
Total Shareholder's Equity | 266 | 267 | -101 | NA | NA |
Total Liabilities & Shareholder's Equity | 344 | 317 | 127 | NA | NA |
Total Common Equity | 266 | 267 | -101 | 0 | 0 |
Shares Outstanding | 48.40 | 33.30 | NA | NA | NA |
Book Value Per Share | 5.49 | 8.02 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for HilleVax, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 303 | 324 | 244 | 261 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 7 | 9 | 9 | 9 |
Total Current Assets | NA | 311 | 333 | 253 | 270 |
Net Property & Equipment | NA | 14 | 14 | 13 | 10 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 2 | 2 | 2 | 2 |
Total Assets | NA | 344 | 367 | 287 | 301 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 7 | 3 | 0 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 19 | 13 | 18 | 17 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 29 | 19 | 18 | 19 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 25 | 25 | 25 | 15 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 1 | 1 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 79 | 68 | 68 | 58 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 655 | 651 | 539 | 535 |
Retained Earnings | NA | -389 | -352 | -320 | -292 |
Other Equity | NA | -1 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 266 | 299 | 219 | 243 |
Total Liabilities & Shareholder's Equity | NA | 344 | 367 | 287 | 301 |
Total Common Equity | 0 | 266 | 299 | 219 | 243 |
Shares Outstanding | 49.70 | 48.40 | 48.40 | 39.20 | 39.20 |
Book Value Per Share | 0.00 | 5.49 | 6.17 | 5.58 | 6.20 |